Home BlogWhen Is The H3 Viral Marker Profile Test Hbsag Hcv Hiv Performed Test Cost Procedure And Results

Book a Home Collection Now!

When Is The H3 Viral Marker Profile Test Hbsag Hcv Hiv Performed Test Cost Procedure And Results

January 13, 2025 - By Lupin Diagnostics

The H3 viral marker profile test is a comprehensive screening panel that checks for three major blood-borne viral infections: Hepatitis B, Hepatitis C, and HIV. These infections often remain silent for years. Without diagnosis and treatment, they can lead to chronic liver disease, cirrhosis, liver cancer, and AIDS. Early screening through the H3 viral marker profile test allows timely intervention, protects partners and families, and supports safer medical care.

This guide explains what the H3 viral marker profile test includes, who should get it, how the HBsAg test and HIV HCV testing are performed, how to interpret results, and what follow-up steps might be needed.

What Is the H3 Viral Marker Profile Test?

The H3 viral marker profile test is a bundled laboratory panel that typically includes:

HBsAg test – for Hepatitis B
HIV HCV testing – usually anti-HCV and HIV antigen/antibody tests

Each component looks for specific markers in the blood that indicate infection.

Hepatitis B surface antigen (HBsAg) is a protein on the surface of the hepatitis B virus (HBV). Its presence usually indicates that a person is currently infected and potentially infectious.
Hepatitis C virus (HCV) is detected either by anti-HCV antibodies or by viral RNA. The WHO and CDC recommend expanded hepatitis C testing in adults and pregnant women to enable earlier diagnosis and cure.
HIV is usually diagnosed through a combination antigen/antibody test or antibody test, often confirmed with supplemental assays.

Because these three viruses share similar transmission routes, blood, sexual contact, and from mother to child, the H3 viral marker profile test offers a convenient, efficient way to screen for them together.

What does H3 Viral Marker Profile Includes

A standard H3 viral marker profile test usually covers the following:

1. HBsAg Test (Hepatitis B Surface Antigen)

The HBsAg test detects hepatitis B surface antigen in the blood. The presence of HBsAg indicates an ongoing HBV infection, acute or chronic. It is often the first serologic marker to appear after infection and plays a central role in HBV screening algorithms.

If positive, the HBsAg test may be followed by additional markers such as anti-HBs and anti-HBc to clarify stage of infection.

2. Anti-HCV Test

For HIV HCV testing, the H3 panel typically uses an anti-HCV antibody assay. This reveals whether a person has ever been exposed to hepatitis C. A positive result is usually followed by HCV RNA testing to confirm whether the infection is active, in line with WHO and CDC guidelines.

3. HIV Antigen/Antibody Test

The HIV component of HIV HCV testing is commonly a fourth-generation combination test that detects both HIV-1/2 antibodies and p24 antigen. This improves early detection of infection compared to older antibody-only tests.

Together, these three tests within the H3 viral marker profile test provide a clear snapshot of a person’s status for HBV, HCV, and HIV.

Who Should Get Tested?

The H3 viral marker profile test is recommended in several situations where hidden infection risk is higher or consequences of missing infection are serious.

1. High-Risk Individuals

People with any of the following should strongly consider H3 viral marker profile test screening:

History of unprotected sex or multiple sexual partners
Intravenous drug use or needle sharing
Past blood transfusions or organ transplants (especially before strict screening protocols)
Healthcare workers with occupational exposures
Partners of people known to be infected

Universal or expanded testing for hepatitis B, HCV, and HIV is increasingly recommended in many countries to identify undiagnosed infections.

2. Pregnant Women

International guidelines now recommend screening pregnant women for hepatitis B, hepatitis C, and HIV to prevent mother-to-child transmission.

The H3 viral marker profile test is often part of routine antenatal panels so that preventive measures, such as neonatal HBV vaccination, antiviral therapy for HCV or HBV, or antiretroviral therapy for HIV, can be implemented.

3. Pre-Surgery and Pre-Transplant Evaluation

Many hospitals perform H3 viral marker profile test screening before major surgery or organ transplantation. This helps protect both medical staff and other patients and allows for special precautions when needed.

4. Symptomatic Individuals

People with symptoms like unexplained fatigue, jaundice, weight loss, recurrent infections, or high liver enzymes may be advised to undergo an H3 viral marker profile test to rule out chronic HBV, HCV, or HIV.

5. Blood Donors and High-Burden Regions

Blood banks routinely use HBsAg tests and HIV HCV testing to ensure safe transfusions. Studies have highlighted the prevalence of HBV, HCV, and HIV among donors and the importance of sensitive screening methods.

How the H3 Viral Marker Profile Test Is Done

The procedure for the H3 viral marker profile test is simple and minimally invasive:

A healthcare professional draws a blood sample from a vein, usually in the arm.
The sample is sent to the laboratory.
Depending on the lab, techniques may include:
- ELISA (enzyme-linked immunosorbent assay) for HBsAg, anti-HCV, and HIV antibodies/antigen
- Rapid tests in some settings for screening
- PCR-based tests (HCV RNA, HIV RNA, HBV DNA) for confirmation or viral load

The CDC and WHO recommend using validated, high-sensitivity assays and following standard testing algorithms, especially for HIV and hepatitis.

Results are usually available within 24–72 hours, depending on the lab and whether confirmatory testing is needed.

Interpretation of Results

Understanding what the H3 viral marker profile test results mean is crucial for both patients and clinicians.

1. HBsAg Test Result

HBsAg Negative – No evidence of current hepatitis B infection. (If needed, anti-HBs can show immunity from vaccination or past infection.)
HBsAg Positive – Indicates current HBV infection; further evaluation (HBV DNA, liver enzymes, additional serology) is needed to clarify acute vs chronic infection and need for treatment.

2. Anti-HCV (Hepatitis C) Result

Anti-HCV Negative – No evidence of past or present infection in most cases.
Anti-HCV Positive – Indicates exposure to hepatitis C. A follow-up HCV RNA test is required to confirm if the infection is active or resolved, per WHO and CDC recommendations.

3. HIV Antigen/Antibody Result

Non-Reactive (Negative) – No evidence of HIV infection at the time of testing, though window periods must be considered.
Reactive (Positive) – Requires confirmatory testing, such as a supplemental antibody differentiation assay and/or HIV RNA test, according to CDC and national algorithms.

The lab report and your clinician’s interpretation should always consider risk history, symptoms, and timing of possible exposure.

Viral Marker Test Cost and Accessibility

The cost of the H3 viral marker profile test varies by city, lab type (private vs government), and whether it is part of a larger health checkup. In many countries, public health programs and national viral hepatitis or HIV initiatives are working to reduce costs and expand free testing access, particularly for hepatitis B, hepatitis C, and HIV.

Some hospitals or government programs even offer free or subsidized HBsAg tests and HIV HCV testing for high-risk groups, pregnant women, or individuals with abnormal liver tests.

What To Do After an Abnormal Result

If the H3 viral marker profile test shows any positive marker, do not panic, but do act promptly.

1. Confirmatory Testing

Positive HBsAg test- HBV DNA, liver function tests, additional serology (anti-HBe, etc.)
Positive Anti-HCV- HCV RNA test to confirm chronic infection and guide therapy.
Positive HIV Screen- Confirmatory antigen/antibody differentiation and HIV RNA test.

2. Specialist Referral

Referral to a hepatologist, infectious disease specialist, or HIV physician may be recommended to discuss:

Stage of disease
Need for antiviral or antiretroviral therapy
Monitoring plans and lifestyle advice

WHO treatment guidelines for hepatitis B and C and national HIV guidelines provide evidence-based treatment pathways.

3. Vaccination and Prevention

If you are negative for HBV and not immune, HBV vaccination is recommended.
Counsel family members or partners to undergo HBsAg test and HIV HCV testing where appropriate.

4. Lifestyle and Safety Measures

After a positive result, your clinician may advise:

Avoiding alcohol (especially in HBV/HCV)
Safe sex practices and partner notification
Avoiding needle sharing or unsafe injections
Regular follow-up blood tests to monitor viral load and organ function

Why the H3 Viral Marker Profile Test Matters

The H3 viral marker profile test is more than a panel of lab values; it is a gateway to prevention, timely treatment, and reduced transmission. WHO estimates that millions of people worldwide live with chronic hepatitis B and C, many undiagnosed, and that HIV remains a significant global burden. Early testing is the first critical step to linking people with life-saving care.

By combining the HBsAg test with HIV HCV testing, the H3 panel makes viral screening more efficient, especially in high-risk groups, pre-operative patients, pregnant women, and blood donors.

If your doctor recommends an H3 viral marker profile test, view it as an important opportunity: understanding your status today can protect your health, and the health of those around you, for years to come.